Kyushu University Academic Staff Educational and Research Activities Database
List of Reports
ICHIRO IEIRI Last modified date:2022.05.25

Professor / Clinical Pharmaceutics / Pharmacy / Kyushu University Hospital

1. Hirota T, Tanaka T, Takesue H, Ieiri I., Epigenetic regulation of drug transporter expression in human tissues., Expert Opin Drug Metab Toxicol., 13(1):19-30., 2017.01.
2. 家入 一郎, Drug-drug interactions that interfere with statin metabolism., Expert Opin Drug Metab Toxicol., 2015.11.
3. 家入 一郎, Clinical impact of genetic variants of drug transporters in different ethnic groups within and across regions., Pharmacogenomics, 2014.01.
4. 家入 一郎, Impact of genetic polymorphisms in CYP2C9 and CYP2C19 on the pharmacokinetics of clinically used drugs, Drug Metab Pharmacokinet, 2013.01.
5. ICHIRO IEIRI, Y. Akamine, Psychotropic drug-drug interactions involving P-glycoprotein., CNS Drugs, 2012.11.
6. Ichiro Ieiri, Functional significance of genetic polymorphisms in P-glycoprotein (MDR1, ABCB1) and breast cancer resistance protein (BCRP, ABCG2)., Drug Metab Pharmacokinet. 2012;27(1):85-105, 2012.03.
7. Ieiri I, Higuchi S, Sugiyama Y, Genetic polymorphisms of uptake (OATP1B1, 1B3) and efflux (MRP2, BCRP) transporters: implications for inter-individual differences in the pharmacokinetics and pharmacodynamics of statins and other clinically relevant drugs., Expert Opin Drug Metab Toxicol., 5(7):703-29. , 2009.06.
8. Takane H, Shikata E, Otsubo K, Higuchi S, Ieiri I., Polymorphism in human organic cation transporters and metformin action., Pharmacogenomics, 9(4):415-22., 2008.04.
9. Hirota T, Takane H, Higuchi S, Ieiri I., Epigenetic regulation of genes encoding drug-metabolizing enzymes and transporters; DNA methylation and other mechanisms., Curr Drug Metab., 9(1):34-8., 2008.01.
10. Ieiri I, Takane H, Hirota T, Otsubo K, Higuchi S., Genetic polymorphisms of drug transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy., Expert Opin Drug Metab Toxicol, 2(5):651-74., 2006.10.
11. Ieiri I., Takane H. and Otsubo K., The MDR1 (ABCB1) gene polymorphism and its clinical implications., Clin Pharmacokinet, 43;553-576., 2004.01.
12. Takane H., Ieiri I. and Otsubo K., Genetic polymorphisms of organic anion and cation transporters: pharmacokinetic and pharmacodynamic consequences in pharmacotherapy., Current Pharmacogenomics, 1;245-257., 2003.01.